growth s t u d i e s . This was i n v e s t i g a t e d by performing 12 consecutive weekly knemometric s e s s i o n s (each c o n s i s t i n g of 6 measurements)
and 4-weekly stadiometry on 31 h e a l t h y c h i l d r e n of 6-12.5 y e a r s of age. The average SD of 6 measurements was 0.12 mm. A r e g r e s s i o n ( l i n e a r and 4 orthogonal polynomials) was computed of 1.1.1. on time. The r e s i d u a l mean square was much h i g h e r than t h e variance within 6 measurements. The l i n e a r r e g r e s s i o n was s i g n i f i c a n t a t 0.05 l e v e l i n 29 c h i l d r e n . Average (fSD) 1.1.1. growth v e l o c i t y was 0.36f0.14 mm/week, and h e i g h t 1.27f0.54 mm/week Q-atio 3.922.0).
The Znd, 3rd, and 4 t h polynomials were s i g n i f i c a n t more o f t e n than expected i f h i g h e r o r d e r e f f e c t s would be absent. When growth vel o c i t i e s were c a l c u l a t e d over t h e f i r s t 6 weeks ( v ) and l a s t 6 weeks (v ) , v and v were d i f f e r e n t from z e r o i n 1 3 and 19 c h i ldren. ~e z n + AD of t i e 31 v v a l u e s were 0.39 and 0.15 mm/week. was s i g n i f i c a n t l y d i f 4 e r e n t from z e r o i n 5 c h i l d r e n . Mean f gh-zh t h e 31 v -v v a l u e s were -0.051f0.23 mm/week. I f a one-slde 2 1 t e s t i s used, a difference v2-v1 g r e a t e r than 0.37 mm/week i s s i gn i f i c a n t . This corresponds wlth a s t a t u r a l growth response of 7. The growth reductions for the two prediction met.hods f o r adult height represent 42% and 24% of the estimated growth potential before treatment. Although the methods for bone age assessment and prediction of adult height are based on data for healthy children, the present results indicate that estrogen treatment may be effective in reducing adult height in girls with Marfan syndrome. Potential beneficial effects o n the development o f scoliosis remain to be clarified. 
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ARGUMENTAL-MODULE METHOD FOR THE STUDY
and Department of Paediatrics and Genetics.University
OF BONE AGE (BA)
The most accepted numerical method for t h e assessment of BA i s Tanner-Whitehouse (TWZ). However,
i t s d i s a d v a ntage i s t h a t i t i s laborious and r e q u i r e s trained s t a f f . A method based on computer a n a l y s i s of bone s h a p e a s indicator of maturity h a s been d e v e l o p e d . The r e p r e s e n t a t iv e p a t t e r n s of e a c h maturity stage of t h e TW2 a t l a s have been d i g i t i z e d b y means of a g r a p h i c b o a r d . The computer calculates t h e g r a v i t y center of t h e figures and r e p r e s e n t e s t h e v e c t o r i a l r a d i u s from t h e center of g r a v i t y t o t h e point of t h e bone perimeter f o r each d i g i t i z e d point on
a coordinate a x i s . The degrees of each vector (0-360Q) correspond t o a x i s X and t h e length of each vector to a x i s Y . The unified e x t r e m e s of t h e v e c t o r s r e s u l t in a r e p r e s e n t a t i v e c u r v e of t h e bone s h a p e . The comparison of a problem c u r v e w i t h t h e catalogue of s t a
n d a r d c u r v e s of TWZ a t l a s h a s demonstrated t h a t t h i s method i s e a s i e r t h a n t h e c l a s s i c method. The automatic comparison of t h e c u r v e s and imaging b y video VICOM system i s p o s s i b l e . The method i s a l s o being a p p l i e d f o r t h e t a r s a l BA of newborns.

Hospital Geneva. Switzerland LACK OF BROMOCRIPTINE-INDUCED REDUCTION OF GROWTH PREDICTION IN TALL ADOLESCENTS It has been suggested that bromocriptine treatment of tall girls and boys reduces growth prediction by inhibiton of growth
hormone secretion (J Clin Endocr Metab 58. 1022-1026.1984) .We have treated 15 girls and 5 boys (chron-age 10.1 -14.6 years. bone age 11.0-14.9 years) with bromocriptine (2x2.5 mglday) over a period of 1.14 -0.31 years (0.6-1.75). Results (paired Wi lcoxon rank test) : The differences between the mean adult height prediction before and after bromocriptine were -0.8 2 3.5 cm according to Bailey-Pinneau (p = 0.433). and t0.2 ' 2.5 cm according to Tanner Mark I (p = 0.586). The mean peak $H values after TRH i .v. were 53.0 ' 50.2 mU/1 before. and 59.0 -50.2 mu11 during bromocriptine treatment (p = 0.314). The wide range of the GH results most probably reflects physiological variations in this age group. Our results are essentially negative. Moreover. the concept. that bromocriptine reduces GH secretion. seems doubtful: in 6 of our patients we have measured plasma GH after 2.5 mg of bromocriptine and found a significant increase within the first three hours.
Our results do not support the data from the literature. We conclude. that bromocriptine is ineffective in reducing adult height of tall girls and boys. controls after 1 yr of follow-up (p less than 0.02).
In conclusion, the pattern of GH secretion in several members By contrast, differences in HP-TWII were not signifiof a family with tall stature was reported. In all the siblings an abnormal GH response to TRH and in 3 tested an increased daily ~~~~. f~~~~~~i~~t t~~s output of GH was found.
by treatment with BRC. BRC was kindly provided by Dr. R. Schmidt, Sandoz Ltd.
